Abstract
Supplementing growth media with a naturally occurring nucleoside has been found to enhance the antitumor and proliferative capabilities of CAR T-cell therapies. Research presented at the Society for Immunotherapy of Cancer's Annual Meeting indicates that inosine triggers metabolic reprogramming within the cells, resulting in a more stem-like state that helps counteract exhaustion.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
